⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10635 | 0.74 | — | — | |
| SCHEMBL84482 | 0.70 | — | — | |
| SCHEMBL82374 | 0.70 | — | — | |
| SCHEMBL477607 | 0.70 | — | — | |
| SCHEMBL13274824 | 0.67 | — | — | |
| SCHEMBL16930146 | 0.67 | — | — | |
| SCHEMBL2865176 | 0.67 | — | — | |
| SCHEMBL6832917 | 0.67 | — | — | |
| SCHEMBL12005028 | 0.67 | — | — | |
| SCHEMBL475047 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680054-B2 | Bronchodilating hetero-linked amides | ARCEDE PHARMA AB (SE) | 2023-06-20 | — | — | US | disclosed |
| EP-3818055-B1 | NOVEL BRONCHODILATING HETERO-LINKED AMIDES | RESPIRATORIUS AB PUBL (SE) | 2022-02-16 | — | — | EP | disclosed |
| US-20210139455-A1 | NOVEL BRONCHODILATING HETERO-LINKED AMIDES | ARCEDE PHARMA AB (SE) | 2021-05-13 | — | — | US | disclosed |
| EP-3818055-A1 | NOVEL BRONCHODILATING HETERO-LINKED AMIDES | Respiratorius AB (Publ) (SE) | 2021-05-12 | — | — | EP | disclosed |
| EP-3548475-B1 | SULFONAMIDE ANALOGUES OF GALIELLALACTONE | GLACTONE PHARMA DEV AB (SE) | 2021-03-03 | — | — | EP | disclosed |
| US-10781197-B2 | Sulfonamide analogues of galiellalactone | GLACTONE PHARMA DEVELOPMENT AB (SE) | 2020-09-22 | — | — | US | disclosed |
| US-20200087274-A1 | SULFONAMIDE ANALOGUES OF GALIELLALACTONE | GLACTONE PHARMA DEVELOPMENT AB (SE) | 2020-03-19 | — | — | US | disclosed |
| WO-2020009653-A1 | NOVEL BRONCHODILATING HETERO-LINKED AMIDES | RESPIRATORIUS AB (PUBL) (SE) | 2020-01-09 | — | — | WO | disclosed |
| EP-3548475-A1 | SULFONAMIDE ANALOGUES OF GALIELLALACTONE | Glactone Pharma Development AB (SE) | 2019-10-09 | — | — | EP | disclosed |
| US-10351577-B2 | Ether analogues of galiellalactone | GLACTONE PHARMA DEVELOPMENT AB (SE) | 2019-07-16 | — | — | US | disclosed |
| WO-2009007419-A1 | NOVEL BRONCHODILATING ISOQUINOLINE CARBAMATES | RESPIRATORIUS AB (SE) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009007418-A1 | NOVEL BRONCHODILATING ISOQUINOLINE AMIDES | RESPIRATORIUS AB (SE) | 2009-01-15 | — | — | WO | disclosed |
| WO-2009007420-A1 | NOVEL BRONCHODILATING ALPHA, BETA-UNSATURATED ISOQUINOLINE AMIDES | RESPIRATORIUS AB (SE) | 2009-01-15 | — | — | WO | disclosed |
| EP-1981883-A1 | NOVEL HETEROARYL SUBSTITUTED BENZOTHIAZOLES | AstraZeneca AB (SE) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008108730-A1 | NOVEL 2-HETEROARYL SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANES 709 | ASTRAZENECA AB (SE) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008108729-A1 | NOVEL 2-HETEROARYL SUBSTITUTED INDOLES 695 | ASTRAZENECA AB (SE) | 2008-09-12 | — | — | WO | disclosed |
| US-20080221149-A1 | 2-[6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol; for imaging amyloid deposits in living patients | ASTRAZENECA AB (SE) | 2008-09-11 | — | — | US | disclosed |
| US-20080027051-A1 | Novel Heteroaryl Substituted Benzoxazoles | ASTRAZENECA AB (SE) | 2008-01-31 | — | — | US | disclosed |
| WO-2007149030-A1 | NOVEL HETEROARYL SUBSTITUTED BENZOXAZOLES | ASTRAZENECA AB (SE) | 2007-12-27 | — | — | WO | disclosed |
| WO-2007086800-A1 | NOVEL HETEROARYL SUBSTITUTED BENZOTHIAZOLES | ASTRAZENECA AB (SE) | 2007-08-02 | — | — | WO | disclosed |